Lilly, Boehringer diabetes drug cuts heart attack, stroke risk in trial
 

Lilly, Boehringer diabetes drug cuts heart attack, stroke risk in trial
Aug 20 (Reuters) - A new diabetes pill from Eli Lilly and Co and Boehringer Ingelheim cut risk of heart attack,stroke and death in a closely watched study, the firstglucose-lowering drug to show...http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...CY:V_sGLiPBpWU http://feeds.feedburner.com/~ff/reut...CY:F7zBnMyn0Lo
http://feeds.feedburner.com/~r/reute...~4/FxG-_eYt8IY